Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Injury
100%
Lipopolysaccharide
100%
Erythropoietin
100%
Galactosamine
100%
Fulminant Hepatic Failure
100%
Recombinant Erythropoietin
70%
Phosphotransferase
30%
Tumor Necrosis Factor
30%
Interleukin 1
30%
Alternative Complement Pathway C3 C5 Convertase
30%
Nuclear Factor
30%
Liver Enzyme
20%
Liver Injury
20%
Western Blot
10%
Overall Survival
10%
Caspase 3
10%
Medicine and Dentistry
Injury
100%
Fulminant Hepatic Failure
100%
Lipopolysaccharide
100%
Erythropoietin
100%
Galactosamine
100%
Recombinant Erythropoietin
70%
Amino Terminal Sequence
30%
Tumor Necrosis Factor
30%
Phosphotransferase
30%
Interleukin 1
30%
Nuclear Factor
30%
Alternative Complement Pathway C3 C5 Convertase
30%
Liver Enzyme
20%
Liver Injury
20%
Hepatocyte
10%
Immunohistochemistry
10%
Fulminant
10%
Liver Transplantation
10%
Overall Survival
10%
C57BL/6
10%
Western Blot
10%
Caspase 3
10%
Keyphrases
Lipopolysaccharide
100%
Fulminant Hepatic Failure
100%
Erythropoietin
100%
D-galactosamine
100%
RhEPO
70%
Kinase Activation
30%
Interleukin-1β
30%
Tumor Necrosis Factor-α
30%
C-Jun N-terminal Kinase
30%
Nuclear factor-B
30%
Serum Liver Enzymes
20%
Hepatic nuclear Factor
20%
Hepatic Tumor
20%
Attenuation
10%
Histological Analysis
10%
Protective Effect
10%
Liver
10%
Immunohistochemistry
10%
Western Blot Analysis
10%
Hepatocytes
10%
Improved Survival
10%
Histologic
10%
C57BL
10%
Apoptotic Cells
10%
Overall Survival
10%
Liver Transplantation
10%
Kaplan-Meier
10%
Caspase-3
10%
Hepatic Injury
10%
Liver Injury
10%
Background Liver
10%